Table 4.
Covariates | Coefficient Β |
OR (COVID-19 vs. pneumonia) | 95% CI | p-value |
---|---|---|---|---|
Age | − 0.022 | 0.978 | [0.968–0.988] | 0.0001 |
Gender (0 = female) | 0.414 | 1.513 | [1.145–2.000] | 0.01 |
Hypertension | 0.740 | 2.096 | [1.560–2.818] | 0.0001 |
Obesity | 0.266 | 1.305 | [0.843–2.019] | 0.23 |
Diabetes type 2 | − 0.355 | 0.701 | [0.494–0.996] | 0.049 |
Dialysis | 3.104 | 22.290 | [7.244–68.590] | 0.0001 |
Chronic kidney disease | − 0.522 | 0.593 | [0.369–0.955] | 0.03 |
Heart failure | 1.095 | 2.990 | [1.612–5.546] | 0.0001 |
COPD | − 0.730 | 0.482 | [0.284–0.817] | 0.01 |
Supraventricular tachyarrhythmia | − 1.687 | 0.185 | [0.116–0.295] | 0.0001 |
Respiratory failure | − 1.045 | 0.352 | [0.203–0.609] | 0.0001 |
Intercept | 0.884 | 2.420 | 0.02 |
In bold the p-values that reached the statistical significance.